Cryselle Kit
Product Images NDC 0555-9049

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cryselle (NDC 0555-9049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram of the active ingredient Norgestrel, showing its steroid backbone and functional groups including an ethynyl group, hydroxyl, and ketone.*

FDA Label Image

Image 2

Chemical structure of Ethinyl Estradiol, an active ingredient in Cryselle (Norgestrel and Ethinyl Estradiol) oral contraceptive kit by Teva Pharmaceuticals USA, Inc.*

FDA Label Image

Image 3

A forest plot chart showing effect estimates with 95% confidence intervals for various women's health cohort studies, including NICHD Women's Contraceptive Study, French E3N cohort Study, Shanghai Women's Health Study, Nurses' Health Study, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The x-axis represents the effect estimate (OR/RR) ranging from -1.5 to 2.0, and each study's effect estimate is displayed with a horizontal line and marker indicating the confidence interval.*

FDA Label Image

Image 4

A data table showing pregnancy rates associated with various birth control methods. The vertical axis ranges from fewer than 1 pregnancy to 85 or more pregnancies per 100 women per year. Methods listed from lowest to higher pregnancy rates include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

Image 5

Cryselle 0.3 mg/0.03 mg tablet kit by Teva Pharmaceuticals USA, Inc., consisting of a 28-pill pack displaying a calendar layout. The pack shows 28 tablets arranged in four rows across days Sunday to Saturday, with white tablets and light-green colored tablets differentiated by week, indicating a 28-day supply.*

FDA Label Image

Image 6

An instructional diagram showing how to apply the day label on a Cryselle tablet kit. The illustration guides users to peel the day label corresponding to their start day of the week and place it onto the tablet pack, which contains 28 tablets labeled with days of the week to help track daily dosage.*

FDA Label Image

Image 7

Cryselle kit containing norgestrel and ethinyl estradiol tablets USP, 0.3 mg/0.03 mg, distributed in 6 blister card dispensers each with 28 tablets. The packaging shows the labeler as Teva Pharmaceuticals USA, Inc. The front includes warnings about the product's use and limitations. The design has vertical stripes with text in blue and green and includes the Teva logo and 'Shaping Women's Health' emblem.*

FDA Label Image

Image 8

Packaging label for Cryselle kit containing norgestrel and ethinyl estradiol tablets USP, 0.3 mg/0.03 mg. The label indicates 6 blister card dispensers with 28 tablets each, produced by Teva Pharmaceuticals USA, Inc. It includes dosage instructions, storage guidelines, and a QR code for additional information. The label also features the Teva logo and the Shaping Women's Health emblem.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.